nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Syncope—Docetaxel—prostate cancer	0.000474	0.000474	CcSEcCtD
Gadodiamide—Pruritus—Estradiol—prostate cancer	0.000474	0.000474	CcSEcCtD
Gadodiamide—Arrhythmia—Prednisone—prostate cancer	0.000467	0.000467	CcSEcCtD
Gadodiamide—Paraesthesia—Etoposide—prostate cancer	0.000466	0.000466	CcSEcCtD
Gadodiamide—Loss of consciousness—Docetaxel—prostate cancer	0.000464	0.000464	CcSEcCtD
Gadodiamide—Dyspnoea—Etoposide—prostate cancer	0.000462	0.000462	CcSEcCtD
Gadodiamide—Malaise—Capecitabine—prostate cancer	0.000461	0.000461	CcSEcCtD
Gadodiamide—Somnolence—Etoposide—prostate cancer	0.000461	0.000461	CcSEcCtD
Gadodiamide—Hypersensitivity—Mitoxantrone—prostate cancer	0.000459	0.000459	CcSEcCtD
Gadodiamide—Syncope—Capecitabine—prostate cancer	0.000459	0.000459	CcSEcCtD
Gadodiamide—Diarrhoea—Estradiol—prostate cancer	0.000458	0.000458	CcSEcCtD
Gadodiamide—Convulsion—Docetaxel—prostate cancer	0.000458	0.000458	CcSEcCtD
Gadodiamide—Chest pain—Docetaxel—prostate cancer	0.00045	0.00045	CcSEcCtD
Gadodiamide—Arthralgia—Docetaxel—prostate cancer	0.00045	0.00045	CcSEcCtD
Gadodiamide—Myalgia—Docetaxel—prostate cancer	0.00045	0.00045	CcSEcCtD
Gadodiamide—Loss of consciousness—Capecitabine—prostate cancer	0.000449	0.000449	CcSEcCtD
Gadodiamide—Renal failure—Epirubicin—prostate cancer	0.000448	0.000448	CcSEcCtD
Gadodiamide—Asthenia—Mitoxantrone—prostate cancer	0.000447	0.000447	CcSEcCtD
Gadodiamide—Fatigue—Etoposide—prostate cancer	0.000447	0.000447	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Epirubicin—prostate cancer	0.000447	0.000447	CcSEcCtD
Gadodiamide—Pain—Etoposide—prostate cancer	0.000444	0.000444	CcSEcCtD
Gadodiamide—Dizziness—Estradiol—prostate cancer	0.000443	0.000443	CcSEcCtD
Gadodiamide—Dry mouth—Docetaxel—prostate cancer	0.00044	0.00044	CcSEcCtD
Gadodiamide—Chest pain—Capecitabine—prostate cancer	0.000435	0.000435	CcSEcCtD
Gadodiamide—Myalgia—Capecitabine—prostate cancer	0.000435	0.000435	CcSEcCtD
Gadodiamide—Arthralgia—Capecitabine—prostate cancer	0.000435	0.000435	CcSEcCtD
Gadodiamide—Anxiety—Capecitabine—prostate cancer	0.000434	0.000434	CcSEcCtD
Gadodiamide—Oedema—Docetaxel—prostate cancer	0.000431	0.000431	CcSEcCtD
Gadodiamide—Anaphylactic shock—Docetaxel—prostate cancer	0.000431	0.000431	CcSEcCtD
Gadodiamide—Discomfort—Capecitabine—prostate cancer	0.00043	0.00043	CcSEcCtD
Gadodiamide—Infection—Docetaxel—prostate cancer	0.000428	0.000428	CcSEcCtD
Gadodiamide—Feeling abnormal—Etoposide—prostate cancer	0.000427	0.000427	CcSEcCtD
Gadodiamide—Diarrhoea—Mitoxantrone—prostate cancer	0.000427	0.000427	CcSEcCtD
Gadodiamide—Dry mouth—Capecitabine—prostate cancer	0.000426	0.000426	CcSEcCtD
Gadodiamide—Vomiting—Estradiol—prostate cancer	0.000426	0.000426	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Etoposide—prostate cancer	0.000424	0.000424	CcSEcCtD
Gadodiamide—Shock—Docetaxel—prostate cancer	0.000424	0.000424	CcSEcCtD
Gadodiamide—Nervous system disorder—Docetaxel—prostate cancer	0.000423	0.000423	CcSEcCtD
Gadodiamide—Ill-defined disorder—Prednisone—prostate cancer	0.000423	0.000423	CcSEcCtD
Gadodiamide—Rash—Estradiol—prostate cancer	0.000422	0.000422	CcSEcCtD
Gadodiamide—Dermatitis—Estradiol—prostate cancer	0.000422	0.000422	CcSEcCtD
Gadodiamide—Tachycardia—Docetaxel—prostate cancer	0.000421	0.000421	CcSEcCtD
Gadodiamide—Headache—Estradiol—prostate cancer	0.000419	0.000419	CcSEcCtD
Gadodiamide—Oedema—Capecitabine—prostate cancer	0.000417	0.000417	CcSEcCtD
Gadodiamide—Renal failure—Doxorubicin—prostate cancer	0.000415	0.000415	CcSEcCtD
Gadodiamide—Infection—Capecitabine—prostate cancer	0.000415	0.000415	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000413	0.000413	CcSEcCtD
Gadodiamide—Urticaria—Etoposide—prostate cancer	0.000412	0.000412	CcSEcCtD
Gadodiamide—Malaise—Prednisone—prostate cancer	0.000411	0.000411	CcSEcCtD
Gadodiamide—Shock—Capecitabine—prostate cancer	0.000411	0.000411	CcSEcCtD
Gadodiamide—Rhinitis—Epirubicin—prostate cancer	0.00041	0.00041	CcSEcCtD
Gadodiamide—Abdominal pain—Etoposide—prostate cancer	0.00041	0.00041	CcSEcCtD
Gadodiamide—Body temperature increased—Etoposide—prostate cancer	0.00041	0.00041	CcSEcCtD
Gadodiamide—Nervous system disorder—Capecitabine—prostate cancer	0.000409	0.000409	CcSEcCtD
Gadodiamide—Syncope—Prednisone—prostate cancer	0.000409	0.000409	CcSEcCtD
Gadodiamide—Tachycardia—Capecitabine—prostate cancer	0.000407	0.000407	CcSEcCtD
Gadodiamide—Pharyngitis—Epirubicin—prostate cancer	0.000406	0.000406	CcSEcCtD
Gadodiamide—Urinary tract disorder—Epirubicin—prostate cancer	0.000404	0.000404	CcSEcCtD
Gadodiamide—Hyperhidrosis—Capecitabine—prostate cancer	0.000403	0.000403	CcSEcCtD
Gadodiamide—Hypotension—Docetaxel—prostate cancer	0.000403	0.000403	CcSEcCtD
Gadodiamide—Urethral disorder—Epirubicin—prostate cancer	0.000401	0.000401	CcSEcCtD
Gadodiamide—Loss of consciousness—Prednisone—prostate cancer	0.0004	0.0004	CcSEcCtD
Gadodiamide—Nausea—Estradiol—prostate cancer	0.000398	0.000398	CcSEcCtD
Gadodiamide—Vomiting—Mitoxantrone—prostate cancer	0.000396	0.000396	CcSEcCtD
Gadodiamide—Convulsion—Prednisone—prostate cancer	0.000395	0.000395	CcSEcCtD
Gadodiamide—Visual impairment—Epirubicin—prostate cancer	0.000394	0.000394	CcSEcCtD
Gadodiamide—Rash—Mitoxantrone—prostate cancer	0.000393	0.000393	CcSEcCtD
Gadodiamide—Dermatitis—Mitoxantrone—prostate cancer	0.000393	0.000393	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000393	0.000393	CcSEcCtD
Gadodiamide—Headache—Mitoxantrone—prostate cancer	0.000391	0.000391	CcSEcCtD
Gadodiamide—Hypotension—Capecitabine—prostate cancer	0.00039	0.00039	CcSEcCtD
Gadodiamide—Arthralgia—Prednisone—prostate cancer	0.000388	0.000388	CcSEcCtD
Gadodiamide—Myalgia—Prednisone—prostate cancer	0.000388	0.000388	CcSEcCtD
Gadodiamide—Paraesthesia—Docetaxel—prostate cancer	0.000387	0.000387	CcSEcCtD
Gadodiamide—Anxiety—Prednisone—prostate cancer	0.000386	0.000386	CcSEcCtD
Gadodiamide—Dyspnoea—Docetaxel—prostate cancer	0.000384	0.000384	CcSEcCtD
Gadodiamide—Somnolence—Docetaxel—prostate cancer	0.000383	0.000383	CcSEcCtD
Gadodiamide—Discomfort—Prednisone—prostate cancer	0.000383	0.000383	CcSEcCtD
Gadodiamide—Hypersensitivity—Etoposide—prostate cancer	0.000382	0.000382	CcSEcCtD
Gadodiamide—Tinnitus—Epirubicin—prostate cancer	0.000382	0.000382	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.00038	0.00038	CcSEcCtD
Gadodiamide—Flushing—Epirubicin—prostate cancer	0.00038	0.00038	CcSEcCtD
Gadodiamide—Rhinitis—Doxorubicin—prostate cancer	0.00038	0.00038	CcSEcCtD
Gadodiamide—Dyspepsia—Docetaxel—prostate cancer	0.000379	0.000379	CcSEcCtD
Gadodiamide—Pharyngitis—Doxorubicin—prostate cancer	0.000376	0.000376	CcSEcCtD
Gadodiamide—Paraesthesia—Capecitabine—prostate cancer	0.000375	0.000375	CcSEcCtD
Gadodiamide—Urinary tract disorder—Doxorubicin—prostate cancer	0.000374	0.000374	CcSEcCtD
Gadodiamide—Asthenia—Etoposide—prostate cancer	0.000372	0.000372	CcSEcCtD
Gadodiamide—Dyspnoea—Capecitabine—prostate cancer	0.000372	0.000372	CcSEcCtD
Gadodiamide—Oedema—Prednisone—prostate cancer	0.000372	0.000372	CcSEcCtD
Gadodiamide—Anaphylactic shock—Prednisone—prostate cancer	0.000372	0.000372	CcSEcCtD
Gadodiamide—Fatigue—Docetaxel—prostate cancer	0.000372	0.000372	CcSEcCtD
Gadodiamide—Urethral disorder—Doxorubicin—prostate cancer	0.000371	0.000371	CcSEcCtD
Gadodiamide—Nausea—Mitoxantrone—prostate cancer	0.00037	0.00037	CcSEcCtD
Gadodiamide—Infection—Prednisone—prostate cancer	0.000369	0.000369	CcSEcCtD
Gadodiamide—Pain—Docetaxel—prostate cancer	0.000369	0.000369	CcSEcCtD
Gadodiamide—Dyspepsia—Capecitabine—prostate cancer	0.000367	0.000367	CcSEcCtD
Gadodiamide—Chills—Epirubicin—prostate cancer	0.000367	0.000367	CcSEcCtD
Gadodiamide—Pruritus—Etoposide—prostate cancer	0.000367	0.000367	CcSEcCtD
Gadodiamide—Shock—Prednisone—prostate cancer	0.000366	0.000366	CcSEcCtD
Gadodiamide—Arrhythmia—Epirubicin—prostate cancer	0.000366	0.000366	CcSEcCtD
Gadodiamide—Visual impairment—Doxorubicin—prostate cancer	0.000365	0.000365	CcSEcCtD
Gadodiamide—Nervous system disorder—Prednisone—prostate cancer	0.000365	0.000365	CcSEcCtD
Gadodiamide—Tachycardia—Prednisone—prostate cancer	0.000363	0.000363	CcSEcCtD
Gadodiamide—Fatigue—Capecitabine—prostate cancer	0.00036	0.00036	CcSEcCtD
Gadodiamide—Hyperhidrosis—Prednisone—prostate cancer	0.000359	0.000359	CcSEcCtD
Gadodiamide—Pain—Capecitabine—prostate cancer	0.000357	0.000357	CcSEcCtD
Gadodiamide—Feeling abnormal—Docetaxel—prostate cancer	0.000355	0.000355	CcSEcCtD
Gadodiamide—Diarrhoea—Etoposide—prostate cancer	0.000355	0.000355	CcSEcCtD
Gadodiamide—Tinnitus—Doxorubicin—prostate cancer	0.000353	0.000353	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Docetaxel—prostate cancer	0.000353	0.000353	CcSEcCtD
Gadodiamide—Flushing—Doxorubicin—prostate cancer	0.000351	0.000351	CcSEcCtD
Gadodiamide—Dysgeusia—Epirubicin—prostate cancer	0.000349	0.000349	CcSEcCtD
Gadodiamide—Feeling abnormal—Capecitabine—prostate cancer	0.000344	0.000344	CcSEcCtD
Gadodiamide—Dizziness—Etoposide—prostate cancer	0.000343	0.000343	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Capecitabine—prostate cancer	0.000341	0.000341	CcSEcCtD
Gadodiamide—Body temperature increased—Docetaxel—prostate cancer	0.000341	0.000341	CcSEcCtD
Gadodiamide—Abdominal pain—Docetaxel—prostate cancer	0.000341	0.000341	CcSEcCtD
Gadodiamide—Chills—Doxorubicin—prostate cancer	0.00034	0.00034	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000339	0.000339	CcSEcCtD
Gadodiamide—Arrhythmia—Doxorubicin—prostate cancer	0.000338	0.000338	CcSEcCtD
Gadodiamide—Paraesthesia—Prednisone—prostate cancer	0.000334	0.000334	CcSEcCtD
Gadodiamide—Urticaria—Capecitabine—prostate cancer	0.000332	0.000332	CcSEcCtD
Gadodiamide—Ill-defined disorder—Epirubicin—prostate cancer	0.000331	0.000331	CcSEcCtD
Gadodiamide—Abdominal pain—Capecitabine—prostate cancer	0.00033	0.00033	CcSEcCtD
Gadodiamide—Body temperature increased—Capecitabine—prostate cancer	0.00033	0.00033	CcSEcCtD
Gadodiamide—Vomiting—Etoposide—prostate cancer	0.00033	0.00033	CcSEcCtD
Gadodiamide—Dyspepsia—Prednisone—prostate cancer	0.000327	0.000327	CcSEcCtD
Gadodiamide—Rash—Etoposide—prostate cancer	0.000327	0.000327	CcSEcCtD
Gadodiamide—Dermatitis—Etoposide—prostate cancer	0.000327	0.000327	CcSEcCtD
Gadodiamide—Headache—Etoposide—prostate cancer	0.000325	0.000325	CcSEcCtD
Gadodiamide—Dysgeusia—Doxorubicin—prostate cancer	0.000323	0.000323	CcSEcCtD
Gadodiamide—Malaise—Epirubicin—prostate cancer	0.000321	0.000321	CcSEcCtD
Gadodiamide—Fatigue—Prednisone—prostate cancer	0.000321	0.000321	CcSEcCtD
Gadodiamide—Syncope—Epirubicin—prostate cancer	0.000319	0.000319	CcSEcCtD
Gadodiamide—Hypersensitivity—Docetaxel—prostate cancer	0.000318	0.000318	CcSEcCtD
Gadodiamide—Loss of consciousness—Epirubicin—prostate cancer	0.000313	0.000313	CcSEcCtD
Gadodiamide—Asthenia—Docetaxel—prostate cancer	0.000309	0.000309	CcSEcCtD
Gadodiamide—Convulsion—Epirubicin—prostate cancer	0.000309	0.000309	CcSEcCtD
Gadodiamide—Nausea—Etoposide—prostate cancer	0.000308	0.000308	CcSEcCtD
Gadodiamide—Hypersensitivity—Capecitabine—prostate cancer	0.000308	0.000308	CcSEcCtD
Gadodiamide—Feeling abnormal—Prednisone—prostate cancer	0.000306	0.000306	CcSEcCtD
Gadodiamide—Ill-defined disorder—Doxorubicin—prostate cancer	0.000306	0.000306	CcSEcCtD
Gadodiamide—Pruritus—Docetaxel—prostate cancer	0.000305	0.000305	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Prednisone—prostate cancer	0.000304	0.000304	CcSEcCtD
Gadodiamide—Arthralgia—Epirubicin—prostate cancer	0.000303	0.000303	CcSEcCtD
Gadodiamide—Chest pain—Epirubicin—prostate cancer	0.000303	0.000303	CcSEcCtD
Gadodiamide—Myalgia—Epirubicin—prostate cancer	0.000303	0.000303	CcSEcCtD
Gadodiamide—Anxiety—Epirubicin—prostate cancer	0.000302	0.000302	CcSEcCtD
Gadodiamide—Discomfort—Epirubicin—prostate cancer	0.0003	0.0003	CcSEcCtD
Gadodiamide—Asthenia—Capecitabine—prostate cancer	0.000299	0.000299	CcSEcCtD
Gadodiamide—Malaise—Doxorubicin—prostate cancer	0.000297	0.000297	CcSEcCtD
Gadodiamide—Dry mouth—Epirubicin—prostate cancer	0.000297	0.000297	CcSEcCtD
Gadodiamide—Syncope—Doxorubicin—prostate cancer	0.000296	0.000296	CcSEcCtD
Gadodiamide—Urticaria—Prednisone—prostate cancer	0.000295	0.000295	CcSEcCtD
Gadodiamide—Pruritus—Capecitabine—prostate cancer	0.000295	0.000295	CcSEcCtD
Gadodiamide—Diarrhoea—Docetaxel—prostate cancer	0.000295	0.000295	CcSEcCtD
Gadodiamide—Abdominal pain—Prednisone—prostate cancer	0.000294	0.000294	CcSEcCtD
Gadodiamide—Body temperature increased—Prednisone—prostate cancer	0.000294	0.000294	CcSEcCtD
Gadodiamide—Anaphylactic shock—Epirubicin—prostate cancer	0.000291	0.000291	CcSEcCtD
Gadodiamide—Oedema—Epirubicin—prostate cancer	0.000291	0.000291	CcSEcCtD
Gadodiamide—Loss of consciousness—Doxorubicin—prostate cancer	0.00029	0.00029	CcSEcCtD
Gadodiamide—Infection—Epirubicin—prostate cancer	0.000289	0.000289	CcSEcCtD
Gadodiamide—Shock—Epirubicin—prostate cancer	0.000286	0.000286	CcSEcCtD
Gadodiamide—Convulsion—Doxorubicin—prostate cancer	0.000286	0.000286	CcSEcCtD
Gadodiamide—Diarrhoea—Capecitabine—prostate cancer	0.000286	0.000286	CcSEcCtD
Gadodiamide—Nervous system disorder—Epirubicin—prostate cancer	0.000285	0.000285	CcSEcCtD
Gadodiamide—Dizziness—Docetaxel—prostate cancer	0.000285	0.000285	CcSEcCtD
Gadodiamide—Tachycardia—Epirubicin—prostate cancer	0.000284	0.000284	CcSEcCtD
Gadodiamide—Hyperhidrosis—Epirubicin—prostate cancer	0.000281	0.000281	CcSEcCtD
Gadodiamide—Arthralgia—Doxorubicin—prostate cancer	0.000281	0.000281	CcSEcCtD
Gadodiamide—Chest pain—Doxorubicin—prostate cancer	0.000281	0.000281	CcSEcCtD
Gadodiamide—Myalgia—Doxorubicin—prostate cancer	0.000281	0.000281	CcSEcCtD
Gadodiamide—Anxiety—Doxorubicin—prostate cancer	0.00028	0.00028	CcSEcCtD
Gadodiamide—Discomfort—Doxorubicin—prostate cancer	0.000277	0.000277	CcSEcCtD
Gadodiamide—Dizziness—Capecitabine—prostate cancer	0.000276	0.000276	CcSEcCtD
Gadodiamide—Dry mouth—Doxorubicin—prostate cancer	0.000274	0.000274	CcSEcCtD
Gadodiamide—Vomiting—Docetaxel—prostate cancer	0.000274	0.000274	CcSEcCtD
Gadodiamide—Hypersensitivity—Prednisone—prostate cancer	0.000274	0.000274	CcSEcCtD
Gadodiamide—Rash—Docetaxel—prostate cancer	0.000272	0.000272	CcSEcCtD
Gadodiamide—Hypotension—Epirubicin—prostate cancer	0.000272	0.000272	CcSEcCtD
Gadodiamide—Dermatitis—Docetaxel—prostate cancer	0.000272	0.000272	CcSEcCtD
Gadodiamide—Headache—Docetaxel—prostate cancer	0.00027	0.00027	CcSEcCtD
Gadodiamide—Anaphylactic shock—Doxorubicin—prostate cancer	0.000269	0.000269	CcSEcCtD
Gadodiamide—Oedema—Doxorubicin—prostate cancer	0.000269	0.000269	CcSEcCtD
Gadodiamide—Infection—Doxorubicin—prostate cancer	0.000267	0.000267	CcSEcCtD
Gadodiamide—Asthenia—Prednisone—prostate cancer	0.000267	0.000267	CcSEcCtD
Gadodiamide—Vomiting—Capecitabine—prostate cancer	0.000265	0.000265	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000265	0.000265	CcSEcCtD
Gadodiamide—Shock—Doxorubicin—prostate cancer	0.000265	0.000265	CcSEcCtD
Gadodiamide—Nervous system disorder—Doxorubicin—prostate cancer	0.000264	0.000264	CcSEcCtD
Gadodiamide—Rash—Capecitabine—prostate cancer	0.000263	0.000263	CcSEcCtD
Gadodiamide—Pruritus—Prednisone—prostate cancer	0.000263	0.000263	CcSEcCtD
Gadodiamide—Dermatitis—Capecitabine—prostate cancer	0.000263	0.000263	CcSEcCtD
Gadodiamide—Tachycardia—Doxorubicin—prostate cancer	0.000263	0.000263	CcSEcCtD
Gadodiamide—Headache—Capecitabine—prostate cancer	0.000261	0.000261	CcSEcCtD
Gadodiamide—Paraesthesia—Epirubicin—prostate cancer	0.000261	0.000261	CcSEcCtD
Gadodiamide—Hyperhidrosis—Doxorubicin—prostate cancer	0.00026	0.00026	CcSEcCtD
Gadodiamide—Dyspnoea—Epirubicin—prostate cancer	0.000259	0.000259	CcSEcCtD
Gadodiamide—Somnolence—Epirubicin—prostate cancer	0.000258	0.000258	CcSEcCtD
Gadodiamide—Nausea—Docetaxel—prostate cancer	0.000256	0.000256	CcSEcCtD
Gadodiamide—Dyspepsia—Epirubicin—prostate cancer	0.000256	0.000256	CcSEcCtD
Gadodiamide—Diarrhoea—Prednisone—prostate cancer	0.000254	0.000254	CcSEcCtD
Gadodiamide—Hypotension—Doxorubicin—prostate cancer	0.000251	0.000251	CcSEcCtD
Gadodiamide—Fatigue—Epirubicin—prostate cancer	0.000251	0.000251	CcSEcCtD
Gadodiamide—Pain—Epirubicin—prostate cancer	0.000249	0.000249	CcSEcCtD
Gadodiamide—Nausea—Capecitabine—prostate cancer	0.000248	0.000248	CcSEcCtD
Gadodiamide—Dizziness—Prednisone—prostate cancer	0.000246	0.000246	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000245	0.000245	CcSEcCtD
Gadodiamide—Paraesthesia—Doxorubicin—prostate cancer	0.000242	0.000242	CcSEcCtD
Gadodiamide—Dyspnoea—Doxorubicin—prostate cancer	0.00024	0.00024	CcSEcCtD
Gadodiamide—Feeling abnormal—Epirubicin—prostate cancer	0.00024	0.00024	CcSEcCtD
Gadodiamide—Somnolence—Doxorubicin—prostate cancer	0.000239	0.000239	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Epirubicin—prostate cancer	0.000238	0.000238	CcSEcCtD
Gadodiamide—Dyspepsia—Doxorubicin—prostate cancer	0.000237	0.000237	CcSEcCtD
Gadodiamide—Vomiting—Prednisone—prostate cancer	0.000236	0.000236	CcSEcCtD
Gadodiamide—Rash—Prednisone—prostate cancer	0.000234	0.000234	CcSEcCtD
Gadodiamide—Dermatitis—Prednisone—prostate cancer	0.000234	0.000234	CcSEcCtD
Gadodiamide—Headache—Prednisone—prostate cancer	0.000233	0.000233	CcSEcCtD
Gadodiamide—Fatigue—Doxorubicin—prostate cancer	0.000232	0.000232	CcSEcCtD
Gadodiamide—Urticaria—Epirubicin—prostate cancer	0.000231	0.000231	CcSEcCtD
Gadodiamide—Pain—Doxorubicin—prostate cancer	0.00023	0.00023	CcSEcCtD
Gadodiamide—Body temperature increased—Epirubicin—prostate cancer	0.00023	0.00023	CcSEcCtD
Gadodiamide—Abdominal pain—Epirubicin—prostate cancer	0.00023	0.00023	CcSEcCtD
Gadodiamide—Feeling abnormal—Doxorubicin—prostate cancer	0.000222	0.000222	CcSEcCtD
Gadodiamide—Nausea—Prednisone—prostate cancer	0.000221	0.000221	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Doxorubicin—prostate cancer	0.00022	0.00022	CcSEcCtD
Gadodiamide—Hypersensitivity—Epirubicin—prostate cancer	0.000214	0.000214	CcSEcCtD
Gadodiamide—Urticaria—Doxorubicin—prostate cancer	0.000214	0.000214	CcSEcCtD
Gadodiamide—Body temperature increased—Doxorubicin—prostate cancer	0.000213	0.000213	CcSEcCtD
Gadodiamide—Abdominal pain—Doxorubicin—prostate cancer	0.000213	0.000213	CcSEcCtD
Gadodiamide—Asthenia—Epirubicin—prostate cancer	0.000209	0.000209	CcSEcCtD
Gadodiamide—Pruritus—Epirubicin—prostate cancer	0.000206	0.000206	CcSEcCtD
Gadodiamide—Diarrhoea—Epirubicin—prostate cancer	0.000199	0.000199	CcSEcCtD
Gadodiamide—Hypersensitivity—Doxorubicin—prostate cancer	0.000198	0.000198	CcSEcCtD
Gadodiamide—Asthenia—Doxorubicin—prostate cancer	0.000193	0.000193	CcSEcCtD
Gadodiamide—Dizziness—Epirubicin—prostate cancer	0.000192	0.000192	CcSEcCtD
Gadodiamide—Pruritus—Doxorubicin—prostate cancer	0.00019	0.00019	CcSEcCtD
Gadodiamide—Vomiting—Epirubicin—prostate cancer	0.000185	0.000185	CcSEcCtD
Gadodiamide—Diarrhoea—Doxorubicin—prostate cancer	0.000184	0.000184	CcSEcCtD
Gadodiamide—Rash—Epirubicin—prostate cancer	0.000183	0.000183	CcSEcCtD
Gadodiamide—Dermatitis—Epirubicin—prostate cancer	0.000183	0.000183	CcSEcCtD
Gadodiamide—Headache—Epirubicin—prostate cancer	0.000182	0.000182	CcSEcCtD
Gadodiamide—Dizziness—Doxorubicin—prostate cancer	0.000178	0.000178	CcSEcCtD
Gadodiamide—Nausea—Epirubicin—prostate cancer	0.000173	0.000173	CcSEcCtD
Gadodiamide—Vomiting—Doxorubicin—prostate cancer	0.000171	0.000171	CcSEcCtD
Gadodiamide—Rash—Doxorubicin—prostate cancer	0.00017	0.00017	CcSEcCtD
Gadodiamide—Dermatitis—Doxorubicin—prostate cancer	0.000169	0.000169	CcSEcCtD
Gadodiamide—Headache—Doxorubicin—prostate cancer	0.000169	0.000169	CcSEcCtD
Gadodiamide—Nausea—Doxorubicin—prostate cancer	0.00016	0.00016	CcSEcCtD
